Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shahzad Malik Insider Profile
4 Followers
Shahzad Malik, Director at Aravive, holds 1.62M shares in Acutus Medical (Ticker: AFIB), holds 1.70M shares in Axonics Modulation Technologies (Ticker: AXNX), holds 1.65M shares in Aravive (Ticker: ARAV).
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+32.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Shahzad Malik holds in companies
Most Profitable Insider Trade
Stock:
Aravive
(ARAV)
(ARAV)
Rating:Informative Sell
Date:Mar 17, 2017 - Mar 17, 2018
Return:+90.50%
The most profitable trade made by Shahzad Malik
Shahzad Malik's Trading History
Aravive
Dec 22, 2017
―
Uninformative Buy
―
$65.82K
Axonics Modulation Technologies
Dec 10, 2018
Director
Uninformative Buy
―
$114.33M
Iterum Therapeutics
―
Director
―
―
Acutus Medical
Jun 22, 2021
Director
Uninformative Buy
―
$199.40K
Agenus
May 27, 2015
Director
Uninformative Buy
10.00M
$19.06M
Histogen
Aug 01, 2013
Director, Ten Percent Owner
Uninformative Buy
211.45K
$346.69K
Emergent Biosolutions
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Shahzad Malik's performance on stock
You May Also Like
Shahzad Malik insider profile FAQ
What is the percentage of profitable transactions made by Shahzad Malik?
The percentage of profitable transactions made by Shahzad Malik is 60%.
What is the average return per transaction made by Shahzad Malik?
The average return per transaction made by Shahzad Malik is 32.20%.
What stocks does Shahzad Malik hold?
Shahzad Malik holds: ARAV, AXNX, ITRM, AFIB, AGEN, HSTO, EBS stocks.
What was Shahzad Malik’s latest transaction?
Shahzad Malik latest transaction was an Uninformative Buy of ―.
What was Shahzad Malik's most profitable transaction?
Shahzad Malik’s most profitable transaction was an Informative Sell of ARAV stock on March 17, 2017. The return on the trade was 90.50%.
What is Shahzad Malik's role in Aravive?
Shahzad Malik's role in Aravive is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.